baber/WOPTO huggingface dataset:
Patent DE-800429-T1 (DE)
Inventor: NIEBAUER KENNETH
IPC: B23B51/04
Filed: 1995-11-09
Abstract: A cutting insert having a chipbreaking configuration for effectively embrittling and breaking thin, foil-like chips produced by drilling or other fine-cutting operations is provided. The cutting insert includes a polygonal insert body having a top surface, a side relief surface, and a cutting edge defined therebetween, and a chipbreaker formed by an elongated groove disposed on the top surface behind the cutting edge in combination with a plurality of recesses disposed over the groove having opposing side edges. The back wall of the groove applies curling forces to the chips, while the opposing side edges of the recesses engage and corrugate the chips thereby embrittling them by work-hardening. The corrugated chips are broken by the curling forces applied by the back and rear walls of the groove and the recesses into small pieces that are easily expelled from the vicinity of the cutting operation.
Patent ES-2085842-T1 (ES)
Title: Dispositivo de disparo para un sistema de retencion de ocupantes.
Inventor: ROHRLE MARTIN
IPC: B60R22/46
Filed: 1995-09-29
Abstract: LA INVENCION SE REFIERE A UN DISPOSITIVO DE DISPARO PARA UN SISTEMA DE RESPALDO DE OCUPANTES, CON UN CUERPO (12) DE INERCIA SENSITIVO DEL VEHICULO, DE FORMA TRASLACIONAL EN UNA CARCASA (10) CONTRA UN RESORTE (14) DE RECUPERACION, OSCILABLE ENTRE UNA PRIMERA POSICION DE REPOSO Y UNA POSICION DE DISPARO, ASI COMO CON UN PERNO (22) PARA LA ACTIVACION DE UNA ESPOLETA (24). DEBE REDUCIRSE EL TIEMPO DE DISPARO Y EVITARSE EL EFECTO DE RETROCESO DE LA RESISTENCIA DE ACCIONAMIENTO DE UN DISPOSITIVO ACTIVADO POR EL DISPOSITIVO DE DISPARO SEGUN EL COMPORTAMIENTO DE DISPOSITIVO DE DISPARO. ESTO SE OBTIENE EN UN DISPOSITIVO DE DISPARO DE ESTE TIPO DE TAL MODO, QUE LOS PERNOS (22) DE ACTIVACION ESTAN IMPULSADOS ELASTICAMENTE Y SOPORTADOS POR MEDIO DE UN TRINQUETE (26) DE GANCHO EN UNA POSICION DE DISPONIBILIDAD, DE TAL MODO QUE EN LA CARCASA (10) SE CARGA UN CUERPO (16) DE CONTROL DESPLAZABLE DE FORMA TRASLACIONAL, POR MEDIO DE UN RESORTE (18) EN UNA POSICION DE DESCANSO, ESTANDO DISPUESTO DE MANERA FUNCIONAL ENTRE EL CUERPO (12) DE INERCIA Y EL TRINQUETE (26) DE GANCHO Y DE MODO QUE EL CUERPO (16) DE CONTROL PUEDE CHOCAR A TRAVES DEL CUERPO (12) DE INERCIA Y ES MOVIL PARA LA RECEPCION DE UNA ENERGIA DE CHOQUE PREVIAMENTE DETERMINADA A PARTIR DE REPOSO A LA POSICION DE LIBERACION, EN DONDE SE LIBERA EL TRINQUETE (26) DE GANCHO PARA LA LIBERACION DEL PERNO (22) DE ACTIVACION.
Patent ES-2156103-T1 (ES)
Inventor: BAIG SYLVIE
IPC: C02F1/72
Filed: 1999-06-04
Abstract: Destruction of organic pollutants in water by ozonization in the presence of a cobalt containing catalyst. Process for catalytic ozonization with molecular ozone or an ozone-containing gas in the purification of polluted water, the ozone being activated with a catalyst comprising at least atoms of Co to promote advanced oxidation of the organic contaminants in the water such that the Total Organic Carbon (TOC) content of the water is converted into CO2.
Patent CY-1107947-T1 (CY)
Title: Θαλαμος αισθησεως πιεσεως υγρου
Inventor: MORGAN MICHAEL
IPC: A61M1/00
Filed: 2008-05-19
Abstract: Παρέχεται χειρουργική κασέτα (200) που έχει ένα θάλαμο αισθήσεως πιέσεως υγρού (210) με μία σωληνοειδή προέκταση (σωλήνα) (240) που εκτείνεται δια μέσου του θαλάμου. Ο σωλήνας περιέχει τουλάχιστον μία θυρίδα (260) που ευχερώς επικοινωνεί (ούν) με το θάλαμο αισθήσεως της πιέσεως, που είναι προσαρμοσμένος ώστε να επιτρέπει τον καθαρισμό του αέρος από το θάλαμο κατά τη διάρκεια της αρχικής εμπυρευμάτησης της κασέτας, αλλά έχοντας ένα τέτοιο μέγεθος ώστε φυσαλίδες αέρος που εισέρχονται στη σωληνοειδή προέκταση δεν μπορούν εύκολα να ρεύσουν μέσα στο θάλαμο.
Patent CY-1109982-T1 (CY)
Title: Ενας κοχλιωτος συνδεσμος σωληνων με συστημα συρματος κλειδωματος
Inventor: PODDAR DEEPAK
IPC: F16L15/08
Filed: 2010-04-26
Abstract: Ένας κοχλιωτός σύνδεσμος σωλήνων με σύστημα σύρματος κλειδώματος που κατασκευάζεται από χλωριούχο πολύ-βινύλιο (polyvinyl chloride) που περιλαμβάνει συνιστώσες σύνδεσης δύο σωλήνων (19,20), δύο δακτυλίους στεγανότητας (13,22), που περιλαμβάνουν ένα σύρμα κλειδώματος (39), όπου το εν λόγω σύρμα κλειδώματος (39) εισάγεται μέσα σε ένα αυλάκι (12,42) που κλειδώνει τον σύνδεσμο (20) και το άκρο της σύνδεσης του ενός σωλήνα, όπου ο εν λόγω σύνδεσμος συνδέει και τα δύο άκρα των σωλήνων χρησιμοποιώντας σπειρώματα, όπου τα εν λόγω σπειρώματα (3, 14), κατασκευάζονται στην μορφή τετραγώνων και οι εν λόγω δακτύλιοι στεγανότητας (22) στερεώνονται και στα δύο άκρα των σωλήνων (19) και του συνδέσμου (20).
Patent CY-1112234-T1 (CY)
Inventor: AHLQVIST ROBERT
IPC: B68G9/00
Filed: 2011-09-20
Abstract: A spring mattress comprising a plurality of interconnected coil springs (1) enclosed in covers (2), known as a pocket-spring mattress, is described, wherein at least two springs that are located adjacent to one another are spaced apart by an interjacent separation distance (SA), said separation distance exceeding approximately 10% of the diameter of the largest one of the spiral turns of the adjacent springs. Also described is a method of manufacturing a corresponding mattress.
Patent CY-1114580-T1 (CY)
Title: Καθαρισμενα πολυμερη για επικαλυψεις εμφυτευσιμων ιατρικων συσκευων
Inventor: DING NI
IPC: A61L31/10
Filed: 2013-11-06
Abstract: Περιγράφεται επικάλυψη για ιατρική συσκευή, ιδιαιτέρως για στεντ έκλουσης φαρμάκου. Η επικάλυψη περιλαμβάνει καθαρισμένο πολυμερές όπως πολυακρυλικό.
Patent CY-1117153-T1 (CY)
Title: Νευροπροστασια σε απομυελινωτικες νοσους
Inventor: GOELZ SUSAN
IPC: A61P25/00
Filed: 2016-01-13
Abstract: Παρέχονται μέθοδοι αγωγής έναντι νευρολογικών νόσων, π.χ. εκείνων που χαρακτηρίζονται από απομυελίνωση και/ή απώλεια νευραξόνων (π.χ. ΣκΠ). Οι μέθοδοι περιλαμβάνουν χορήγηση υπό θεραπευτικά αποτελεσματικό ποσό τουλάχιστον μίας ένωσης Τύπου I: (I) όπου R1 και R2 επιλέγονται ανεξάρτητα από ΟΗ, Ο¯, και (C1-6)αλκοξυ-ομάδα, ή φαρμακευτικά αποδεκτού άλατος αυτής· και είτε οξική γλατιραμέρη ή ιντερφερόνη β.
Patent CY-1117600-T1 (CY)
Title: Συζυγη διζοραζολιων και παραγωγα τους με μορια κυτταρικης συνδεσης, νεα παραγωγα διζοραζολιου, μεθοδοι παραγωγης και χρησεις τους
Inventor: Günther Eckhard
IPC: C07K14/655
Filed: 2016-06-03
Abstract: Η παρούσα εφεύρεση παρέχει συζυγή διζοραζολίων και τα παράγωγα τους με μόρια κυτταρικής σύνδεσης, όπως πεπτίδια, πρωτεΐνες, ορμόνες, πρωτεΐνες αίματος και αντισώματα. Η παρούσα εφεύρεση παρέχει περαιτέρω νέα παράγωγα διζοραζολίου και μεθόδους παραγωγής τέτοιων συζυγών και παραγώγων διζοραζολίου. Αυτές οι ενώσεις μπορούν να χρησιμοποιηθούν ως φάρμακα για τη θεραπεία φυσιολογικών και/ή παθοφυσιολογικών καταστάσεων σε θηλαστικά, συγκεκριμένα για τη θεραπεία ποικίλων όγκων.
Patent CY-1117659-T1 (CY)
Title: Υδατικο διαλυμα που περιλαμβανει 3-κινουκλιδινονες για τη θεραπεια υπερπλαστικης, αυτοανοσης και καρδιακης ασθενειας
Inventor: BYSTRÖM STYRBJÖRN
IPC: A61P35/00
Filed: 2016-06-17
Abstract: Μια υγρή σύνθεση η οποία είναι ένα υδατικό διάλυμα μιας ένωσης με τύπο (I), στην οποία το υδατικό διάλυμα έχει ένα pΗ από περίπου 3.0 έως περίπου 5.0. Η υγρή σύνθεση μπορεί να χρησιμοποιηθεί στην θεραπεία μιας διαταραχής που επιλέγεται από υπερπλαστικές ασθένειες, αυτοάνοσες ασθένειες και καρδιακές ασθένειες.
Patent CY-1120540-T1 (CY)
Title: ΜΕΘΟΔΟΙ ΧΟΡΗΓΗΣΗΣ ΑΝΤΙΣΩΜΑΤΩΝ ANTI-TNFa
Inventor: KEMPENI JOACHIM
IPC: A61P19/02
Filed: 2017-02-08
Abstract: Αποκαλύπτονται μέθοδοι θεραπευτικής αγωγής διαταραχών, στις οποίες η δραστικότητα TNFα είναι επιβλαβής, μέσω δισεβδομαδιαίας, υποδόριας χορήγησης ανθρώπινων αντισωμάτων, κατά προτίμηση ανασυνδυασμένων ανθρώπινων αντισωμάτων, που δεσμεύονται ειδικά με ανθρώπινο παράγοντα νέκρωσης όγκων άλφα (hTNFα). Το αντίσωμα μπορεί να χορηγηθεί με ή χωρίς μεθοτρεξάτη. Αυτά τα αντισώματα έχουν υψηλή συγγένεια για hTNFα (π.χ., Kd= 10-8 Μ ή λιγότερο), αργό ρυθμό διάστασης για αποσύνδεση από hTNFα (π.χ., Κoff= 10-3 sec-1 ή λιγότερο) και εξουδετερώνουν την δραστικότητα του hTNFα in vitro και in vivo. Αντίσωμα της εφεύρεσης μπορεί να είναι αντίσωμα πλήρους μήκους ή τμήμα αυτού που δεσμεύεται με αντιγόνο. Κιτ που περιέχουν φαρμακευτική σύνθεση και οδηγίες για χορήγηση δόσεων, και προγεμισμένες σύριγγες που περιέχουν φαρμακευτικές συνθέσεις περιλαμβάνονται επίσης στην εφεύρεση
Patent CY-1119474-T1 (CY)
Title: Κρυσταλλικες μορφες 5-χλωρο-ν2-(2-ισοπροποξυ-5-μεθυλ-4-πιπεριδιν-4-υλ-φαινυλ)-ν4[2-(προπανο-2-σουλφονυλ)-φαινυλ]-πυριμιδιν-2,4-διαμινης
Inventor: FENG LILI
IPC: C07D401/12
Filed: 2017-10-11
Abstract: Η παρούσα εφεύρεση περιγράφει συγκεκριμένες κρυσταλλικές μορφές 5-χλωρο-Ν- (2-ισοπροποξυ-5-μεθυλ-4- (πιπεριδιν-4-υλφαινυλ) -Ν-2-(ισοπροπυλσουλφονυλ) φαινυλ) -2,4-διαμίνης. Η παρούσα εφεύρεση περαιτέρω σχετίζεται με μεθόδους για παρασκευή των εν λόγω κρυσταλλικών μορφών, φαρμακευτικών συνθέσεων που περιλαμβάνουν τις εν λόγω κρυσταλλικές μορφές, και μεθόδους για χρήση των εν λόγω κρυσταλλικών μορφών και φαρμακευτικών συστατικών στη θεραπεία ασθένειας.
Patent CY-1123994-T1 (CY)
Title: Δικυκλικες-συντηγμενες ενωσεις ετεροαρυλιου ή αρυλιου ως ρυθμιστες της irak4
Inventor: LEE KATHERINE LIN
IPC: C07D401/12
Filed: 2021-04-05
Abstract: Δημοσιοποιούνται ενώσεις, ταυτομερή και φαρμακευτικά αποδεκτά άλατα των ενώσεων, όπου οι ενώσεις έχουν τη δομή του Τύπου la, όπως ορίζεται στην προδιαγραφή. Δημοσιοποιούνται επίσης αντίστοιχες φαρμακευτικές συνθέσεις, μέθοδοι θεραπείας, μέθοδοι σύνθεσης, και ενδιάμεσα.
Patent GR-900300019-T1 (GR)
Title: Optical network
Inventor: BORN SIJTZE
IPC: H04L12/28
Filed: 1991-06-07
Abstract: A network in which not only the transmission of control signals and information signals in transmission sections (1, 1a), but also the switching in switching devices (24) and the joining or the separation of the control signals and information signals take place in the optical domain. The control signals (c) and the information signals (d) in the optical domain are distinguishable from each other, and they are both coupled in and out in one and the same optical conductor (1, 1a). For distinguishing the control signal from the information signal the transmission modes (e.g. the wavelength or the polarization mode) thereof can be different. A distinction between the control signal and the information signal can also be effected by opposite directions of transmission; for controlling a switching device a control signal is then transmitted to the switching device via a glass fibre which at the same time serves for the transmission of information signals in an opposite direction.
Patent GR-910300025-T1 (GR)
Title: Procedure for the continuous manufacture of wall elements and installation which utilizes such procedure
Inventor: VAN DEN EYNDE J
IPC: E04C2/52
Filed: 1991-11-15
Abstract: Procedure for the continuous manufacture of wall elements, characterized in that the different walls are effected continuously on a suitable transport system whereby these walls are assembled in vertical position on this transport system and whereby this procedure consists of at least the following steps; the placing of upper and lower beams (1); the connecting together of the extremities of these upper and lower beams (2) placed behind each other without taking into consideration the length of the walls to be effected with regard to the length of these upper and lower beams; the installation of the windows and doors (3); the placing of the vertical posts (4); the placing of a first covering (5); the installation of electricity wires, sanitary pipes and utility pipes (6); the installation of insulating material (7); the installation of the second covering (8); the sawing out of the coverings at the location of the doors and/or windows (9); the sawing off to measure of the different walls (10).
Patent HR-P20100123-T1 (HR)
Inventor: STUMPF ANDREAS
IPC: C07F7/18
Filed: 2010-03-05
Abstract: Postupak pripravljanja spoja formule (III): koji sadrži: omogućavanje spoju formule (I): da reagira u prisutnosti smjese spoja formule R1SR2 i trikloroizocijanurne kiseline, pod uvjetima koji su dovoljni da se pripravi spoj formule (II): i (b) omogućavanje spoju formule (II) da reagira s prvom bazom i agensom za aciliranje formule R4(C(O)OC(O)R4 ili R4C(O)X pod uvjetima koji su dovoljni da se pripravi spoj formule (III), gdje: R1 i R2 su svaki neovisno -(C1-C20)alkil, -(C3-C8)cikloalkil ili fenil; R3 je zaštitna skupina; R4 je -(C1-C10)alkil; iX je -Cl, -Br ili -I. Patent sadrži još 22 patentna zahtjeva.
Patent HR-P20110607-T1 (HR)
Title: Thioxanthene derivates as sole anti-infective agents for use in the treatment of infectious diseases
Inventor: GIWERCMAN BIRGIT KJOLGAARD
IPC: A61P31/04
Filed: 2011-08-17
Abstract: The present invention is directed to certain thioxanthene derivatives and phenothiazine derivatives suitable for use as anti-infective agents, in particular, for treatment of infectious diseases. The invention furthermore relates to compositions comprising said anti-infective agents.
Patent HR-P20180004-T1 (HR)
Title: Machine-readable form configuration and systems and method for interpreting at least one user mark
Inventor: Diamandis Argiris
IPC: G06K9/20
Filed: 2018-01-03
Abstract: Method and system for detecting user marks, comprising placing a form in a field of view of a camera, wherein the form includes thereon at least a first fiducial mark and a second fiducial mark; wherein the fiducial marks both comprise an outline portion and an interior portion; detecting the first and second fiducial marks; utilizing the camera to generate an electronic image of at least a portion of the form; calculating a distance between at least the first fiducial mark and the second fiducial mark; detecting at least a first user marking cell on the form based at least in part upon the calculated distance between the first fiducial mark and the second fiducial mark; calculating a displacement vector of the detected first user marking cell versus an ideal planar position of the detected first user marking cell; detecting at least a second user marking cell on the form, wherein the second user marking cell is detected based at least in part upon the displacement vector of the detected first user marking cell; determining evidence of at the first and second user marks based at least in part upon a degree of brightness similarity between: (a) at least a portion of the electronic image surrounding the indicium bounding the respective user marking cell; and (b) at least a portion of the electronic image included inside the indicium bounding the respectiveuser marking cell.
Patent SI-1529057-T1 (SI)
Title: Biphalin derivatives and their analgesic applications
Inventor: LIPKOWSKI ANDRZEJ W
IPC: C07K14/00
Filed: 2003-08-07
Abstract: Provided are compounds represented by: wherein R1 is a D-alanine, D-serine, D-threonine, D-methionine, D-leucine, D-asparagine or D-glutamine side chain and R2 is a phenylalanine or tryptophan side-chain, and compositions containing such compounds.
Patent SI-1827873-T1 (SI)
Title: A paint tray and a packaging
Inventor: NOER TORBEN
IPC: B44D3/00
Filed: 2005-12-07
Abstract: The invention relates to a paint roller tray (10) for a container (101) comprising a container bottom (106) , a round-going container wall (5) delimiting the container (101) and having opposite the container bottom (106) a mouthing with an expanse delimited by the container wall (5) , and wherein the paint roller tray (10) comprises a bottom with a bottom face (11) , a round-going sidewall (15) delimiting the paint roller tray (10) and having opposite the bottom face (11) being configured with a single -curvature course, a free edge (18) defining the upper opening of the tray (10) ; and that the tray (10) comprises means for arrangement of the paint roller tray (10) in a position at the mouthing of the container (101) .
Patent SI-2049113-T1 (SI)
Title: Medicament for the enhancement of cognitive function and neuroprotection
Inventor: GACSALYI ISTVAN
IPC: A61K31/501
Filed: 2007-07-03
Abstract: The invention relates the use of 4-chloro-5-{2-[4-(6-fluoro-1,2-benz[d]isoxazole-3-yl)piperidin-1-yl]ethyl-amino}-2-methyl-3-(2H)pyridazinone of the Formula (I) or pharmaceutically acceptable salts thereof for the preparation of medicaments suitable for the improvement of cognitive function or obtaining neuroprotective effect. The medicaments containing 4-chloro-5-{2-[4-(6-fluoro-1,2-benz[d]isoxazol-3-yl)piperidin-1-yl]ethyl-amino}-2-methyl-3-(2H)pyridazinone of the Formula (I) or therapeutically acceptable salt thereof can be used for the treatment or prevention of neuronal death, mental decline, sclerosis multiplex, Creuzfeld-Jacobs disease, Huntington-syndrome, amyotrophic lateral sclerosis, Parkinson-disease, memory disturbance, loss of memory, amnesia, stroke or for the improvement of memory function or learning ability.
Patent TR-200800419-T1 (TR)
Title: Bir kompresör
Inventor: DOENMEZ ERSIN
IPC: F04B39/12
Filed: 2006-08-04
Abstract: Bu buluş, soğutucularda kullanılan bir hermetik kompresörde (1), çevrim akışkanı sıcaklığının yükseltilmeden emme susturucudan (6) silindire (2) ulaşması sağlanan, susturucu kafası (9) - silindir kafası (3) bağlantısı ile ilgilidir.
Patent DE-3650377-T2 (DE)
Inventor: ROHRSCHNEIDER LARRY
IPC: A61K31/435
Filed: 1986-11-26
Granted: 1996-02-22
Abstract: Glucosidase I inhibitors as therapeutic agents for combatting nondefective retroviral pathogens, including the aetiological agents of AIDS and feline leukemia. Administration of a processing glucosidase I inhibitor, preferably castanospermine, interrupts the replication of the retrovirus in infected cells, alleviates pathogenic effects associated with the presentation of vital env glycoproteins on infected cells, and may furthermore prevent infection of target cells by interrupting expression of endogenous receptors recognized by the virion.
Patent DE-3688561-T2 (DE)
Inventor: GLEASON JOHN GERALD
IPC: C07D307/40
Filed: 1986-04-14
Granted: 1993-09-23
Abstract: Intermediates of structure: <CHEM> wherein Y is CO2R10 or CH(R12)CO2R10 in which R10 is an ester protective group and R10 is hydrogen, methyl, methoxy or fluoro, and their use for the preparation of leukotriene antagonists.
Patent DE-3873914-T2 (DE)
Inventor: HARRISON JOHN
IPC: B41M5/26
Filed: 1988-02-12
Granted: 1993-02-25
Abstract: Phthalocyanine of formula (I), wherein M is a metal or is 2H, bonded at 29 and 31 positions shown, R1 to R8 are the same or different and are independently selected from C1 to C20 alkyl, C1-C20 alkenyl, -X-COO-X1, -X-O-Y, a, and -X-COZ where X is independently selected from a chemical bond, (CH2)n where n-0-20 or (CH2)a CH-CH (CH2)b where a and b are independently selected from 0-20 and a+b is in the range 0-20, X1 is independently selected from C1-C20 alkyl or C2-C20 alkenyl, Y is independently selected from C1-C20 alkyl, C2-C20 alkenyl or H and Z is selected from OH or NR1R11 are independently selected from H, C1-C20 alkyl and C2-C20 alkenyl. These phthalocyanines may exhibit discotic liquid crystal phases, absorb infra-red radiation and make good Langmuir-Blodgett films.
Patent DE-3874049-T2 (DE)
Inventor: BAHL LALIT RAI
IPC: G10L15/06
Filed: 1988-06-16
Granted: 1993-04-08
Abstract: Apparatus and method for training the statistics of a Markov Model speech recognizer to a subsequent speaker who utters part of a training text after the recognizer has been trained for the statistics of a reference speaker who utters a full training text. Where labels generated by an acoustic processor in response to uttered speech serve as outputs for Markov models, the present apparatus and method determine label output probabilities at transitions in the Markov models corresponding to the subsequent speaker where there is sparse training data. Specifically, label output probabilities for the subsequent speaker are re-parameterized based on confusion matrix entries having values indicative of the similarity between an  l th label output of the subsequent speaker and a kth label output for the reference speaker. The label output probabilities based on re-parameterized data are combined with initialized label output probabilities to form "smoothed" label output probabilities which feature smoothed probability distributions. Based on label outputs generated when the subsequent speaker utters the shortened training text, "basic" label output probabilities computed by conventional methodology are linearly averaged against the smoothed label output probabilities to produce improved label output probabilities.
Patent DE-3881033-T2 (DE)
Inventor: CIAMPI LUIGI
IPC: D06M16/00
Filed: 1988-10-27
Granted: 1993-12-02
Abstract: The invention relates to a process for the production of wool and animal hairs with a low-in felt or felt-free finish, with a soft woolly handle and special shrink-resistance and strength. In this process, the wool is treated with a protease and is then treated at a temperature of between room temperature and 140 DEG C.
Patent TR-199802223-T2 (TR)
Inventor: WATSON RANDALL ALAN
IPC: C11D3/386
Filed: 1997-04-25
Abstract: Daha fazla kumas temizleme yarari saglayan bazi degistirilmis poliaminlerle birlikte C12-C14 dimetil hidroksietil kuaterner amonyum katyonik yüzey aktif maddeler içeren çamasir deterjani bilesimleri.
Patent TR-199802698-T2 (TR)
Inventor: WAGNER ROBERT FRANK
IPC: A61K47/36
Filed: 1997-06-18
Abstract: Mevcut bulus asagidakileri ihtiva eden kati oral doz formlarina iliskindir. a) valsartan ve ihtiyari olarak HCTZ' den seçilmis bir aktif madde, ve b) sikistirma yöntemleri yoluyla kati oral doz formlarinin hazirlanmasi için uygun olan eczasal olarak kabul edilebilir katki maddeleri.
Patent TR-199902011-T2 (TR)
Inventor: COLLINS GEOFFREY WILLIAM
IPC: D06P5/08
Filed: 1998-02-18
Abstract: Selülozik malzemeler, kumasin, ayni zamanda polinükleofilik olmasi da istenen bir polikatyonik polimerik madde ile ön muamele edilmesiyle  reaktif boya ile boyanmaktadir. Madde, bir polikuaterner amin malzeme, özellikle, bir poli(DADMAC)ya da polivinilpiridin mazemedir, özellikle, primer amino grplari gibi nükleofilik mevkileri kapsayan, örnegin , w-aminoalkil gruplari ile kuatenrize edilmis polivinilpiridinler ve polialilamin/DADMAC kopolimerleridir. Boyalar, nükleofilik merkezler ile reaksiyona girebilmekte, böylece, boya banyosu doymasi, alt-tabakaya saglam yerlesme yerine boya sabitleme ile gelistirilebilmektedir. Yerlesme kuvvetinin gelistirilmesi için tuzlarin kullanilma ihtiyacinin önüne geçilebilmekte ve reaksiyona girmemis/hidrolize olmus boyanin ayrilmasi için boyama sonrasi yikama çok basitlesmektedir.Yöntem ile boyanan malzeme, reaktif boyalarin kullanilmasiyla boyanmis malzemelerin iyi yikanma saglamligi özelliklerine sahiptir.Aralarinda liyosel elyaf malzemeleri